Fiduciary Trust CO Bristol Myers Squibb CO Transaction History

Fiduciary Trust CO

  • $6.98 Billion
  • Q3 2024

A detailed history of Fiduciary Trust CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Fiduciary Trust CO holds 179,560 shares of BMY stock, worth $10.1 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
179,560
Previous 181,425 1.03%
Holding current value
$10.1 Million
Previous $7.53 Million 23.33%
% of portfolio
0.13%
Previous 0.12%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$39.66 - $51.75 $73,965 - $96,513
-1,865 Reduced 1.03%
179,560 $9.29 Million
Q2 2024

Aug 14, 2024
SELL
$40.25 - $52.99 $1.32 Million - $1.74 Million
-32,747 Reduced 15.29%
181,425 $7.53 Million
Q1 2024

May 13, 2024
SELL
$47.98 - $54.4 $385,567 - $437,158
-8,036 Reduced 3.62%
214,172 $11.6 Million
Q4 2023

Feb 12, 2024
BUY
$48.48 - $57.85 $1.47 Million - $1.75 Million
30,257 Added 15.76%
222,208 $11.4 Million
Q3 2023

Nov 14, 2023
SELL
$57.89 - $64.73 $80,409 - $89,909
-1,389 Reduced 0.72%
191,951 $11.1 Million
Q2 2023

Aug 01, 2023
BUY
$63.71 - $70.74 $235,727 - $261,737
3,700 Added 1.95%
193,340 $12.4 Million
Q1 2023

May 15, 2023
BUY
$65.71 - $74.53 $314,750 - $356,998
4,790 Added 2.59%
189,640 $13.1 Million
Q4 2022

Feb 13, 2023
BUY
$68.48 - $81.09 $517,571 - $612,878
7,558 Added 4.26%
184,850 $13.3 Million
Q3 2022

Nov 14, 2022
BUY
$0.13 - $76.84 $1,167 - $689,869
8,978 Added 5.33%
177,292 $12.6 Million
Q2 2022

Aug 12, 2022
SELL
$72.62 - $79.98 $54,610 - $60,144
-752 Reduced 0.44%
168,314 $13 Million
Q1 2022

May 12, 2022
BUY
$61.48 - $73.72 $104,946 - $125,840
1,707 Added 1.02%
169,066 $12.3 Million
Q4 2021

Feb 14, 2022
SELL
$53.63 - $62.52 $241,013 - $280,964
-4,494 Reduced 2.62%
167,359 $10.4 Million
Q3 2021

Nov 12, 2021
BUY
$59.17 - $69.31 $33,786 - $39,576
571 Added 0.33%
171,853 $10.2 Million
Q2 2021

Aug 16, 2021
SELL
$61.91 - $67.42 $699,211 - $761,441
-11,294 Reduced 6.19%
171,282 $11.4 Million
Q1 2021

May 19, 2021
SELL
$59.34 - $66.74 $365,297 - $410,851
-6,156 Reduced 3.26%
182,576 $11.5 Million
Q4 2020

Jan 26, 2021
BUY
$57.74 - $65.43 $1.07 Million - $1.21 Million
18,515 Added 10.88%
188,732 $11.7 Million
Q3 2020

Nov 13, 2020
SELL
$57.43 - $63.64 $66,159 - $73,313
-1,152 Reduced 0.67%
170,217 $10.3 Million
Q2 2020

Aug 13, 2020
BUY
$54.82 - $64.09 $1.69 Million - $1.98 Million
30,851 Added 21.96%
171,369 $10.1 Million
Q1 2020

May 15, 2020
BUY
$46.4 - $67.43 $534,528 - $776,793
11,520 Added 8.93%
140,518 $7.83 Million
Q4 2019

Feb 04, 2020
BUY
$49.21 - $64.19 $2.13 Million - $2.78 Million
43,299 Added 50.52%
128,998 $8.28 Million
Q3 2019

Nov 12, 2019
BUY
$42.77 - $50.71 $229,375 - $271,957
5,363 Added 6.68%
85,699 $4.35 Million
Q2 2019

Aug 14, 2019
SELL
$44.62 - $49.34 $121,232 - $134,056
-2,717 Reduced 3.27%
80,336 $3.64 Million
Q1 2019

May 07, 2019
SELL
$45.12 - $53.8 $134,006 - $159,786
-2,970 Reduced 3.45%
83,053 $3.96 Million
Q4 2018

Jan 29, 2019
BUY
$48.76 - $63.23 $41,397 - $53,682
849 Added 1.0%
86,023 $4.47 Million
Q3 2018

Nov 13, 2018
SELL
$55.19 - $62.25 $15,177 - $17,118
-275 Reduced 0.32%
85,174 $5.29 Million
Q2 2018

Aug 03, 2018
BUY
$50.53 - $62.98 $32,743 - $40,811
648 Added 0.76%
85,449 $4.73 Million
Q1 2018

May 08, 2018
SELL
$59.92 - $68.98 $66,511 - $76,567
-1,110 Reduced 1.29%
84,801 $5.36 Million
Q4 2017

Jan 29, 2018
SELL
$59.94 - $65.35 $124,435 - $135,666
-2,076 Reduced 2.36%
85,911 $5.27 Million
Q3 2017

Nov 02, 2017
BUY
$55.23 - $63.74 $4.86 Million - $5.61 Million
87,987
87,987 $5.61 Million

Others Institutions Holding BMY

# of Institutions
2,533
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Fiduciary Trust CO Portfolio

Follow Fiduciary Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiduciary Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Fiduciary Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email